3rd Quarter - Report

PHARMAVITE LLC for PHARMAVITE LLC

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Discussed FDA's NDI guidance document issued 2011 and need to have FDA issue revised draft. Support for both HR 4771 and SB 2012. Support for full enforcement of DSHEA. Dept of Commerce meeting - discuss regulatory hurdles relative to marketing dietary supplement products in China.

LobbyistCovered position, as disclosed
CAROLYN J SABATINI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 4771 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.